Heather Jacene, MD

Publications

• Messersmith WA, Jimeno A, Jacene H, Zhao M, Kulesza P, Laheru DA, Kahn Y, Spira A, Dancey J, Iacobuzio-Donahue C, Donehower RC, Carducci M, Rudek MA, Hidalgo M.Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotini
  21208844
• Goudarzi B, Jacene HA, Wahl RL.Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.Acad Radiol. 2010 Sep;17(9):1175-85.
  20634105
• Lyford-Pike S, Ha PK, Jacene HA, Saunders JR, Tufano RP.Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.Orl; Journal For Oto Rhino Laryngology And Its Related Sp
  19776658
• Jacene HA, Leboulleux S, Baba S, Chatzifotiadis D, Goudarzi B, Teytelbaum O, Horton KM, Kamel I, Macura KJ, Tsai HL, Kowalski J, Wahl RL.Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to thera
  19837757
• Wahl RL, Jacene H, Kasamon Y, Lodge MA.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.J Nucl Med. 2009 May;50 Suppl 1:122S-50S. Review.
  19403881